| Freddy R Mendez Torres, MD | |
|
Edificio Profesional Suite 211, Hospital Menonita, Cayey, PR 00736 | |
| (787) 535-1001 | |
| (787) 535-1069 |
| Full Name | Freddy R Mendez Torres |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 28 Years |
| Location | Edificio Profesional Suite 211, Cayey, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982772141 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 13214 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Menonita De Cayey | Cayey, PR | Hospital |
| Entity Name | Jc Island Lithotripsy Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386815264 PECOS PAC ID: 3779751904 Enrollment ID: O20110714000272 |
News Archive
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
More than 9,000 people from more than 90 countries will gather Dec. 8-12, 2010, at the Henry B. Gonzales Convention Center in San Antonio, Texas, for the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.
Smoke inhalation is the major cause of death in fire victims due to cyanide poisoning. However, new research presented at CHEST 2012, the annual meeting of the American College of Chest Physicians, shows that a new antidote, cobinamide, may help reverse the effects of cyanide toxicity.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
› Verified 9 days ago
| Entity Name | Urology Hub Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164023081 PECOS PAC ID: 9537572243 Enrollment ID: O20210119000412 |
News Archive
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
More than 9,000 people from more than 90 countries will gather Dec. 8-12, 2010, at the Henry B. Gonzales Convention Center in San Antonio, Texas, for the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.
Smoke inhalation is the major cause of death in fire victims due to cyanide poisoning. However, new research presented at CHEST 2012, the annual meeting of the American College of Chest Physicians, shows that a new antidote, cobinamide, may help reverse the effects of cyanide toxicity.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Freddy R Mendez Torres, MD Po Box 372876, Cayey, PR 00737-2876 Ph: () - | Freddy R Mendez Torres, MD Edificio Profesional Suite 211, Hospital Menonita, Cayey, PR 00736 Ph: (787) 535-1001 |
News Archive
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
More than 9,000 people from more than 90 countries will gather Dec. 8-12, 2010, at the Henry B. Gonzales Convention Center in San Antonio, Texas, for the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.
Smoke inhalation is the major cause of death in fire victims due to cyanide poisoning. However, new research presented at CHEST 2012, the annual meeting of the American College of Chest Physicians, shows that a new antidote, cobinamide, may help reverse the effects of cyanide toxicity.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
› Verified 9 days ago
Dr. Felix Mendoza Rosa, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 22 Heraclio Mendoza St., Cayey, PR 00736 Phone: 787-263-3131 Fax: 787-738-8457 |